Spark Investment Management LLC Aerie Pharmaceuticals Inc Transaction History

Spark Investment Management LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2020 Feb 11, 2021	SELL	$9.12 - $14.49 $92,111 - $146,349	-10,100 Closed	0 $0
Q3 2020 Nov 12, 2020	SELL	$10.46 - $14.46 $86,818 - $120,018	-8,300 Reduced 45.11%	10,100 $118,000
Q2 2020 Aug 12, 2020	SELL	$12.0 - $16.13 $298,800 - $401,637	-24,900 Reduced 57.51%	18,400 $271,000
Q4 2019 Feb 11, 2020	SELL	$17.72 - $25.1 $290,608 - $411,640	-16,400 Reduced 27.47%	43,300 $1.05 Million
Q3 2019 Nov 12, 2019	SELL	$18.41 - $28.0 $1.13 Million - $1.71 Million	-61,200 Reduced 50.62%	59,700 $1.15 Million
Q2 2019 Aug 12, 2019	SELL	$28.97 - $48.21 $1.05 Million - $1.75 Million	-36,300 Reduced 23.09%	120,900 $3.57 Million
Q4 2018 Feb 12, 2019	BUY	$33.0 - $60.04 $5.19 Million - $9.44 Million	157,200 New	157,200 $5.67 Million

2.4M

Ticker AERI
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 49,390,500
Description
Aerie Pharmaceuticals, Inc., a pharmaceutical company, focuses on the discovery, development, and commercialization of ophthalmic therapies for open-angle glaucoma, dry eye, diabetic macular edema, and wet age-related macular degeneration in the United States. Its products include Rhopressa, a once-daily eye drop to reduce elevated intraocular p...

Get notified when there are updates to the investment portfolio of Spark Investment Management LLC, based on Form 13F filings with the SEC.

Stay updated on Spark Investment Management LLC with notifications on news.